0.7906USD-3.59%Mkt Cap: 41.34M USDP/E: —Last update: 2026-05-26
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized fo…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
56.52BEURP/E 22.3
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap41.34M USD
Enterprise Value27.83M USD
Revenue (TTM)1.00K USD
Gross Profit-245.00K USD
Net Income (TTM)-14.29M USD
Revenue/Share0.0000 USD
Last Price0.7906 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.27
PEG—
EV/EBITDA—
EV/Revenue27829.34
P/S42438.34
P/B2.37
EPS (TTM)-0.28
EPS (Forward)-0.25
52W Range
0.380035% of range1.570
52W High1.570 USD
52W Low0.3800 USD
Profitability
Gross Margin0.00%
Oper. Margin-1451600.00%
EBITDA Margin0.00%
Profit Margin-51035.71%
ROE-83.89%
ROA-48.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.36M USD
CapEx (TTM)—
FCF Margin-577750.00%
FCF Yield-13.98%
Net Debt-14.61M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity35.17
Current Ratio5.30
Quick Ratio5.24
Book Value/Sh0.3450 USD
Cash/Share0.4070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 26, 2022
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)3.250 USD
Target Range3.000 USD – 3.500 USD
# Analysts2
Ownership
Shares Out.51.90M
Float26.75M
Insiders24.25%
Institutions34.76%
Short Interest
Short Ratio7.5d
Short % Float2.47%
Short % Out.2.00%
Shares Short1.04M
Short (prev mo.)1.27M
Technical
SMA 500.8116 (-2.6%)
SMA 2000.9403 (-15.9%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)140.86K
Avg Vol (10d)164.41K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—